148 related articles for article (PubMed ID: 38695582)
1. Polyfluoroalkyl Tag Decoration Enables Significantly Enhanced Tumor Penetration Ability of a PTK7 Targeting Aptamer.
Li Y; Zhang C; Fu T; Wang XQ; Tan W
Bioconjug Chem; 2024 May; 35(5):674-681. PubMed ID: 38695582
[TBL] [Abstract][Full Text] [Related]
2. Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept.
Calzada V; Moreno M; Newton J; González J; Fernández M; Gambini JP; Ibarra M; Chabalgoity A; Deutscher S; Quinn T; Cabral P; Cerecetto H
Bioorg Med Chem; 2017 Feb; 25(3):1163-1171. PubMed ID: 28089349
[TBL] [Abstract][Full Text] [Related]
3. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
[TBL] [Abstract][Full Text] [Related]
4. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM.
Leitner M; Poturnayova A; Lamprecht C; Weich S; Snejdarkova M; Karpisova I; Hianik T; Ebner A
Anal Bioanal Chem; 2017 Apr; 409(11):2767-2776. PubMed ID: 28229174
[TBL] [Abstract][Full Text] [Related]
6. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
7. Technical and biological issues relevant to cell typing with aptamers.
Li N; Ebright JN; Stovall GM; Chen X; Nguyen HH; Singh A; Syrett A; Ellington AD
J Proteome Res; 2009 May; 8(5):2438-48. PubMed ID: 19271740
[TBL] [Abstract][Full Text] [Related]
8. Molecular Engineering of Aptamer Self-Assemblies Increases
Xia F; He A; Zhao H; Sun Y; Duan Q; Abbas SJ; Liu J; Xiao Z; Tan W
ACS Nano; 2022 Jan; 16(1):169-179. PubMed ID: 34935348
[TBL] [Abstract][Full Text] [Related]
9. An exploration of aptamer internalization mechanisms and their applications in drug delivery.
Wan LY; Yuan WF; Ai WB; Ai YW; Wang JJ; Chu LY; Zhang YQ; Wu JF
Expert Opin Drug Deliv; 2019 Mar; 16(3):207-218. PubMed ID: 30691313
[TBL] [Abstract][Full Text] [Related]
10. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-Functionalized Upconverting Nanoformulations for Light-Switching Cancer-Specific Recognition and
Jin X; Zeng Q; Zheng J; Xing D; Zhang T
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9316-9328. PubMed ID: 33089995
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted drug delivery with aptamers.
Zhang Y; Hong H; Cai W
Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours.
Liu M; Ma W; Li Q; Zhao D; Shao X; Huang Q; Hao L; Lin Y
Cell Prolif; 2019 Jan; 52(1):e12511. PubMed ID: 30311693
[TBL] [Abstract][Full Text] [Related]
14. Noncovalent tethering of nucleic acid aptamer on DNA nanostructure for targeted photo/chemo/gene therapies.
Shim G; Park J; Kim MG; Yang G; Lee Y; Oh YK
Nanomedicine; 2020 Feb; 24():102053. PubMed ID: 31344502
[TBL] [Abstract][Full Text] [Related]
15. Cabazitaxel liposomes with aptamer modification enhance tumor‑targeting efficacy in nude mice.
Cheng Y; Ou Z; Li Q; Yang J; Hu M; Zhou Y; Zhuang X; Zhang ZJ; Guan S
Mol Med Rep; 2019 Jan; 19(1):490-498. PubMed ID: 30483775
[TBL] [Abstract][Full Text] [Related]
16. A basic insight into aptamer-drug conjugates (ApDCs).
Xuan W; Peng Y; Deng Z; Peng T; Kuai H; Li Y; He J; Jin C; Liu Y; Wang R; Tan W
Biomaterials; 2018 Nov; 182():216-226. PubMed ID: 30138784
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific internalization study of an aptamer from whole cell selection.
Xiao Z; Shangguan D; Cao Z; Fang X; Tan W
Chemistry; 2008; 14(6):1769-75. PubMed ID: 18092308
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.
Mahajan UM; Li Q; Alnatsha A; Maas J; Orth M; Maier SH; Peterhansl J; Regel I; Sendler M; Wagh PR; Mishra N; Xue Y; Allawadhi P; Beyer G; Kühn JP; Marshall T; Appel B; Lämmerhirt F; Belka C; Müller S; Weiss FU; Lauber K; Lerch MM; Mayerle J
Gastroenterology; 2021 Sep; 161(3):996-1010.e1. PubMed ID: 34097885
[TBL] [Abstract][Full Text] [Related]
19. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
20. The potential of aptamers for cancer research.
Zhou Z; Liu M; Jiang J
Anal Biochem; 2018 May; 549():91-95. PubMed ID: 29548926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
